Nasivin Zatoki I Katar (Pseudoephedrine Hydrochloride, Ibuprofen)

Pseudoephedrine acts as an α‑adrenergic agonist. By stimulating α‑receptors on the blood vessels of the nasal mucosa, it causes vasoconstriction, which reduces swelling and opens the nasal passages, making breathing easier.

The appropriate dose is determined by a qualified prescriber based on the patient’s age, weight, medical condition and other medications. Patients should follow the specific instructions provided by their healthcare professional.

Safety in pregnancy and lactation has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their doctor before using this medication.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

When used separately, pseudoephedrine only relieves nasal congestion, while ibuprofen only addresses pain, fever and inflammation. The combination in Nasivin Zatoki I Katar provides simultaneous decongestant and analgesic/anti‑inflammatory effects, which can simplify therapy for patients experiencing multiple symptoms.

Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and keep out of reach of children.

The product is taken orally with a full glass of water. It should be swallowed whole and not chewed or crushed unless a healthcare professional advises otherwise.

Serious risks include a significant rise in blood pressure or hypertension, severe allergic reactions such as anaphylaxis, and gastrointestinal bleeding or ulceration, especially in patients with a history of ulcers or who take other NSAIDs.

The product should be avoided in individuals with known hypersensitivity to pseudoephedrine, ibuprofen or any excipients, in patients with uncontrolled hypertension, severe coronary artery disease, active peptic ulcer disease, or in those taking monoamine oxidase inhibitors.